Latest Shareholder Capital Raising News

Infini Resources has successfully raised AUD$3.4 million through a flow-through share placement at a significant premium, positioning the company to aggressively advance exploration at its Portland Creek Uranium Project in Newfoundland.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.